Aptevo Therapeutic Revenue, Growth & Competitor Profile

DBA Aptevo Therapeutics Inc.
DBA APTEVO THERAPEUTICS RESEARCH AND DEVELOPMENT, LLC

Company Profile & Annual Report for Aptevo Therapeutic

Access the complete profile.

Aptevo Therapeutic Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	5417 Scientific Research & Development Services
Address	2401 4th Ave Suite 1050 Seattle, WA 98121

Note: Revenues for privately held companies are statistical evaluations.


Aptevo Therapeutic's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Aptevo Therapeutic's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Aptevo Therapeutic is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Aptevo Therapeutic Annual Revenue and Growth Rate

Aptevo Therapeutic	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Aptevo Therapeutic's revenues are gauged from an analysis of company filings.

Aptevo Therapeutic's Income Statement (based on Industry Averages)

Aptevo Therapeutic P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Aptevo Therapeutic is developing and marketing. Aptevo Therapeutic doesn't have any recent trademark applications, indicating Aptevo Therapeutic is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
VYDAPTIV Pharmaceutical preparations for the treatment and prophylaxis of infectious diseases, cancer and immune system diseases and disorders, auto immune system diseases, and blood disorders	04/12/2016
VYDAPTIV BIOPHARMA Pharmaceutical preparations for the treatment and prophylaxis of infectious diseases, cancer and immune system diseases and disorders, auto immune system diseases, and blood disorders	09/16/2015

See all trademarks and details in the Full Report.

Market Share of Aptevo Therapeutic's Largest Competitors

A competitive analysis shows these companies are in the same general field as Aptevo Therapeutic, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Aptevo Therapeutic. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
JUST-EVOTEC BIOLOGICS	Seattle, WA	100
IMPEL PHARMACEUTICALS	Seattle, WA	61
TILRAY	Seattle, WA	48
UMOJA BIOPHARMA	Seattle, WA	32
ZYMEWORKS BIOPHARMACEUTICALS	Seattle, WA	21
APTEVO THERAPEUTIC	Seattle, WA	11

Future Competition: Aptevo Therapeutic's Fastest Growing Competitors

These companies are in the same general field as Aptevo Therapeutic and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)